Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes
Open Access
- 1 January 2010
- journal article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 8 (1) , 6
Abstract
Plasmid DNA encoding a luciferase reporter gene was complexed with each of six different hybrid nanoparticles (NPs) synthesized from mixtures of poly (D, L-lactide-co-glycolide acid) (PLGA 50:50) and the cationic lipids DOTAP (1, 2-Dioleoyl-3-Trimethyammonium-Propane) or DC-Chol {3β-[N-(N', N'-Dimethylaminoethane)-carbamyl] Cholesterol}. Particles were 100-400 nm in diameter and the resulting complexes had DNA adsorbed on the surface (out), encapsulated (in), or DNA adsorbed and encapsulated (both). A luciferase reporter assay was used to quantify DNA expression in 293 cells for the uptake of six different NP/DNA complexes. Optimal DNA delivery occurred for 105 cells over a range of 500 ng - 10 μg of NPs containing 20-30 μg DNA per 1 mg of NPs. Uptake of DNA from NP/DNA complexes was found to be 500-600 times as efficient as unbound DNA. Regression analysis was performed and lines were drawn for DNA uptake over a four week interval. NP/DNA complexes with adsorbed NPs (out) showed a large initial uptake followed by a steep slope of DNA decline and large angle of declination; lines from uptake of adsorbed and encapsulated NPs (both) also exhibited a large initial uptake but was followed by a gradual slope of DNA decline and small angle of declination, indicating longer times of luciferase expression in 293 cells. NPs with encapsulated DNA only (in), gave an intermediate activity. The latter two effects were best seen with DOTAP-NPs while the former was best seen with DC-Chol-NPs. These results provide optimal conditions for using different hybrid NP/DNA complexes in vitro and in the future, will be tested in vivo.Keywords
This publication has 44 references indexed in Scilit:
- Cytotoxic-T-Lymphocyte-Mediated Elimination of Target Cells Transduced with Engineered Adeno-Associated Virus Type 2 Vector In VivoJournal of Virology, 2009
- Nucleic Acids Electrotransfer-Based Gene Therapy (Electrogenetherapy): Past, Current, and FutureMolecular Biotechnology, 2009
- Nanoparticles for human liver-specific drug and gene delivery systems:in vitroandin vivoadvancesExpert Opinion on Drug Delivery, 2009
- In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinomaThe Journal of Gene Medicine, 2008
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Preparation of polylactide-co-glycolide and chitosan hybrid microcapsules of amifostine using coaxial ultrasonic atomizer with solvent evaporationJournal of Pharmacy and Pharmacology, 2008
- Formulation and In Vivo Evaluation of Effervescent Inhalable Carrier Particles for Pulmonary Delivery of NanoparticlesDrug Development and Industrial Pharmacy, 2008
- Long-Term In Vivo Gene Expression via Delivery of PEI–DNA Condensates from Porous Polymer ScaffoldsHuman Gene Therapy, 2005
- Local perivascular application of low amounts of a plasmid encoding for vascular endothelial growth factor (VEGF165) is efficient for therapeutic angiogenesis in pigsActa Physiologica Scandinavica, 2002
- Next-generation adenoviral vectors: new and improvedGene Therapy, 1999